Literature DB >> 3601492

Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles.

V G Tamashiro, H H Perez, D E Griffin.   

Abstract

The suppression of cellular immune responses during measles is thought to contribute to the development of secondary infections which often complicate this disease. To determine whether there was a difference in the altered cellular immune responses of children with and without complications we performed a prospective study of purified protein derivative skin test reactivity in children with natural measles virus infections who had received Bacillus Calmette-Guerin as infants. Twenty-five tuberculin-positive children who developed measles (13 uncomplicated and 12 complicated) were skin-tested weekly beginning 1 to 2 weeks before and ending 2 to 7 weeks after the onset of the rash. All children became anergic during the acute phase of measles. Children with complications remained unreactive for a significantly longer period of time after the rash (mean, 4 weeks) than did children without complications (mean, 2.3 weeks, P less than 0.001).

Entities:  

Mesh:

Year:  1987        PMID: 3601492     DOI: 10.1097/00006454-198705000-00007

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  36 in total

1.  Multicenter Safety and Immunogenicity Trial of an Attenuated Measles Vaccine for NHP.

Authors:  Joann L Yee; Michael B McChesney; Kari L Christe
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

2.  Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins.

Authors:  S Niewiesk; I Eisenhuth; A Fooks; J C Clegg; J J Schnorr; S Schneider-Schaulies; V ter Meulen
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 3.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

4.  Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection.

Authors:  J Mongkolsapaya; A Jaye; M F Callan; A F Magnusen; A J McMichael; H C Whittle
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

5.  Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression.

Authors:  J J Schnorr; S Xanthakos; P Keikavoussi; E Kämpgen; V ter Meulen; S Schneider-Schaulies
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles.

Authors:  Judith J Ryon; William J Moss; Mwaka Monze; Diane E Griffin
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

7.  Cell cycle arrest during measles virus infection: a G0-like block leads to suppression of retinoblastoma protein expression.

Authors:  D Naniche; S I Reed; M B Oldstone
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

Review 8.  [Recommendations for the diagnosis and prevention of infectious diseases in pediatric and adolescent refugees in Germany : Statement of the German Society of Pediatric Infectious Diseases, the Society of Tropical Pediatrics and International Child Health, and the Professional Association of Pediatricians].

Authors:  J Pfeil; R Kobbe; S Trapp; C Kitz; M Hufnagel
Journal:  Internist (Berl)       Date:  2016-05       Impact factor: 0.743

9.  Induction of dendritic cell production of type I and type III interferons by wild-type and vaccine strains of measles virus: role of defective interfering RNAs.

Authors:  Rupak Shivakoti; Martina Siwek; Debra Hauer; Kimberly L W Schultz; Diane E Griffin
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

10.  Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression.

Authors:  Julien C Marie; Frédéric Saltel; Jean-Michel Escola; Pierre Jurdic; T Fabian Wild; Branka Horvat
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.